Table 3.
Association between clinical parameters and VA/SCD
| Parameters | Presence of VT/VF/SCD | ||
|---|---|---|---|
| OR | 95% CI | P value | |
| Male | 0.82 | 0.35–1.93 | 0.656 |
| Age | 0.99 | 0.95–1.02 | 0.474 |
| BMI | 0.96 | 0.84–1.10 | 0.592 |
| History of syncope | 2.67 | 1.00–7.13 | 0.050 |
| Adjusted 2004 Mayo stage | |||
| II | 1 | ||
| IIIa | 2.91 | 1.00–8.52 | 0.051 |
| IIIb | 2.31 | 0.82–6.53 | 0.113 |
| NYHA III-IV | 0.97 | 0.30–3.17 | 0.959 |
| Atrial flutter/fibrillation | 1.75 | 0.74–4.16 | 0.202 |
| Hypertension | 1.54 | 0.63–3.81 | 0.346 |
| CAD | 1.63 | 0.70–3.75 | 0.255 |
| Diabetes mellitus | 1.20 | 0.36–3.98 | 0.763 |
| Aortic valve disease | 0.20 | 0.03–1.56 | 0.125 |
| CKD | 1.35 | 0.58–3.14 | 0.480 |
| eGFR | 0.99 | 0.98–1.01 | 0.195 |
| cTNI | 2.27 | 0.34–15.35 | 0.401 |
| D-Dimer | 1.04 | 0.89–1.21 | 0.639 |
| NT-proBNP (ln) | 1.55 | 1.02–2.35 | 0.039 |
| Serum creatinine | 1.00 | 0.99–1.01 | 0.681 |
| BUN | 1.05 | 0.97–1.12 | 0.235 |
| LVEDD | 1.08 | 1.01–1.17 | 0.035 |
| LVEF | 0.99 | 0.96–1.03 | 0.789 |
| Interventricular septum thickness | 0.96 | 0.84–1.10 | 0.566 |
| Posterior LV thickness | 1.03 | 0.86–1.22 | 0.780 |
| Multi-morphological PVC | 4.32 | 0.57–32.85 | 0.158 |
NYHA, New York Heart association; BMI, body mass index; VT, ventricular tachycardia; VF, ventricular fibrillation; SCD, sudden cardiac death; cTnI, cardiac troponin I; NT-proBNP, N-terminal pro-B-type natriuretic peptide; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic diameter; CAD, coronary artery disease; CKD, chronic kidney disease; LVPW, left ventricular posterior wall; PVC, premature ventricular contraction; OR, Odds ratio; CI, confidence interval.